A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

Clinical trial NCT00244244 · COMPLETED

Trial details

NCT number: NCT00244244
Sponsor: CytRx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2005-10-01
Primary completion: 2007-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.